Task: Answer the multiple-choice question.
Question: Which drug exhibits a 0.296% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CN(CC(=O)O/N=C(\N)c1ccc([N+](=O)[O-])cc1)S(=O)(=O)c1ccc2ccccc2c1
(b) CCCc1cc(=O)oc2cc(C)cc(OC(C)C(=O)NCCN3CCOCC3)c12
Answer: b. CCCc1cc(=O)oc2cc(C)cc(OC(C)C(=O)NCCN3CCOCC3)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(=O)oc2cc(C)cc(OC(C)C(=O)NCCN3CCOCC3)c12
CCCc1cc(=O)oc2cc(C)cc(OC(C)C(=O)NCCN3CCOCC3)c12
2-(7-methyl-2-oxo-4-propylchromen-5-yl)oxy-N-(2-morpholin-4-ylethyl)propanamide